tiprankstipranks
Hisamitsu Pharmaceutical Co Inc (JP:4530)
:4530
Japanese Market
4530
Hisamitsu Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4530 full AI Analyst Report?

Hisamitsu Pharmaceutical Co (4530) Financial Statements

2 Followers

Hisamitsu Pharmaceutical Co Financial Overview

Hisamitsu Pharmaceutical Co's market cap is currently ¥440.70B. The company's EPS TTM is ¥102.79; its P/E ratio is 22.45; and it has a dividend yield of 2.43%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on April 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 26Feb 25Feb 24Feb 23Feb 22
Income Statement
Total Revenue¥ 163.02B¥ 156.01B¥ 141.71B¥ 128.33B¥ 120.19B
Gross Profit¥ 96.12B¥ 91.20B¥ 78.97B¥ 72.70B¥ 70.07B
Operating Income¥ 17.92B¥ 18.89B¥ 13.17B¥ 11.60B¥ 9.34B
EBITDA¥ 24.97B¥ 35.04B¥ 24.37B¥ 21.08B¥ 17.30B
Net Income¥ 19.16B¥ 21.76B¥ 13.97B¥ 11.74B¥ 9.66B
Balance Sheet
Cash & Short-Term Investments¥ 118.64B¥ 129.12B¥ 125.32B¥ 136.87B¥ 142.43B
Total Assets¥ 367.16B¥ 343.07B¥ 328.78B¥ 313.92B¥ 302.86B
Total Debt¥ 2.38B¥ 3.86B¥ 2.10B¥ 2.29B¥ 2.46B
Net Debt¥ -106.48B¥ -110.66B¥ -110.36B¥ -119.86B¥ -126.83B
Total Liabilities¥ 72.47B¥ 63.66B¥ 61.69B¥ 55.51B¥ 47.97B
Stockholders' Equity¥ 291.82B¥ 276.83B¥ 264.88B¥ 256.37B¥ 253.17B
Cash Flow
Free Cash Flow¥ 9.48B¥ 5.14B¥ 5.26B¥ 4.87B¥ 15.59B
Operating Cash Flow¥ 17.48B¥ 18.77B¥ 18.19B¥ 12.73B¥ 19.20B
Investing Cash Flow¥ -16.87B¥ 17.56B¥ -2.51B¥ -23.87B¥ -13.06B
Financing Cash Flow¥ -20.20B¥ -15.85B¥ -16.69B¥ -14.69B¥ -15.19B
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History

Income Statement >

Hisamitsu Pharmaceutical Co Debt to Assets

Balance Sheet >

Hisamitsu Pharmaceutical Co Cash Flow

Cash Flow >

Hisamitsu Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >